You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 61 No. 4, April 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurocutaneous Diseases
 •Dermatology
 •Dermatologic Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Role of Methionine in Ethylmalonic Encephalopathy with Petechiae

Karen A. McGowan, MD; William L. Nyhan, MD, PhD; Bruce A. Barshop, MD, PhD; Robert K. Naviaux, MD, PhD; Alice Yu, MD, PhD; Richard H. Haas, MD; Jeannette J. Townsend, MD

Arch Neurol. 2004;61:570-574.

Background  Among patients with ethylmalonic aciduria, a subgroup with encephalopathy, petechial skin lesions, and often death in infancy is distinct from those with short-chain acyl-coenzyme A dehydrogenase deficiency or multiple acyl-coenzyme A dehydrogenase deficiency. The nature of the molecular defect in this subgroup is unknown, and the source of the ethylmalonic acid has been unclear.

Objective  To determine whether the administration of candidate amino acids increased the excretion of ethylmalonic acid.

Design  Examination of patterns of organic acids excreted in the urine before and following loading doses of isoleucine and methionine.

Setting  General clinical research center.

Patient  An infant with ethylmalonic aciduria, global developmental delay, acrocyanosis, and intermittent showers of petechiae.

Main Outcome Measure  Excretion of ethylmalonic acid in the urine.

Results  Loading with methionine increased the excretion of ethylmalonic acid, whereas loading with isoleucine did not. Restriction of the dietary intake of methionine decreased ethylmalonic acid excretion.

Conclusion  In ethylmalonic acid encephalopathy with petechiae, methionine is a precursor of ethylmalonic acid.


From the Institute of Molecular Genetics (Drs McGowan, Nyhan, Barshop, Yu, and Haas) and the Departments of Pediatrics (Drs McGowan, Nyhan, Barshop, Yu, and Haas), Medicine (Dr Naviaux), and Neurosciences (Dr Haas), University of California San Diego, La Jolla; and the Department of Pathology, University of Utah, Salt Lake City (Dr Townsend).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Heterogeneity in Ethylmalonic Encephalopathy
Pigeon et al.
J Child Neurol 2009;24:991-996.
ABSTRACT  

2-Ethylhydracrylic Aciduria in Short/Branched-Chain Acyl-CoA Dehydrogenase Deficiency: Application to Diagnosis and Implications for the R-Pathway of Isoleucine Oxidation
Korman et al.
Clin. Chem. 2005;51:610-617.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.